{"transactions":[{"id":1925964,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:02:23.000Z","date":"2023-04-03","kind":"gift","planned":false,"acquired":false,"shares":259,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":125493,"source":{"system":"sec-edgar","filing":"0001968202-23-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000007/edgardoc.xml","form_type":"4"}},{"id":1938446,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-27T20:42:44.000Z","date":"2023-03-23","kind":"gift","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 21, 2022."}],"balance_after":312578,"source":{"system":"sec-edgar","filing":"0001883850-23-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000063/edgardoc.xml","form_type":"4"}},{"id":1994400,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-24T21:07:17.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":85000,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001883850-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000050/edgardoc.xml","form_type":"4"}},{"id":1994399,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:07:17.000Z","date":"2023-01-04","kind":"gift","acquired":false,"shares":291,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":125752,"source":{"system":"sec-edgar","filing":"0001883850-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000050/edgardoc.xml","form_type":"4"}},{"id":1994398,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:07:17.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":29005,"price":750.16,"value":21758390.8,"ownership":{"direct":true},"balance_after":337578,"source":{"system":"sec-edgar","filing":"0001883850-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000050/edgardoc.xml","form_type":"4"}},{"id":1994397,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T21:07:17.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":42500,"price":270.43,"value":11493275.0,"ownership":{"direct":true},"balance_after":366583,"source":{"system":"sec-edgar","filing":"0001883850-23-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000050/edgardoc.xml","form_type":"4"}},{"id":2079158,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-21T22:45:22.000Z","date":"2022-12-20","kind":"other","acquired":false,"shares":111,"price":729.71,"value":80997.81,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 111 shares of Company stock on December 20, 2022 at prices ranging from $729.44 to $729.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price."}],"balance_after":1961,"source":{"system":"sec-edgar","filing":"0001883850-22-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000141/edgardoc.xml","form_type":"4"}},{"id":2079157,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-21T22:45:22.000Z","date":"2022-12-20","kind":"other","acquired":false,"shares":30,"price":728.86,"value":21865.8,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 30 shares of Company stock on December 20, 2022 at prices ranging from $728.81 to $728.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price."}],"balance_after":2072,"source":{"system":"sec-edgar","filing":"0001883850-22-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000141/edgardoc.xml","form_type":"4"}},{"id":2080322,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T22:44:48.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":16254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":16254,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":16254},"source":{"system":"sec-edgar","filing":"0001883850-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000139/edgardoc.xml","form_type":"4"}},{"id":2080321,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T22:44:48.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":1651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock."}],"balance_after":324083,"source":{"system":"sec-edgar","filing":"0001883850-22-000139","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000139/edgardoc.xml","form_type":"4"}},{"id":2088770,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:12:47.000Z","date":"2022-10-03","kind":"gift","acquired":false,"shares":304,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":126043,"source":{"system":"sec-edgar","filing":"0001883850-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000121/edgardoc.xml","form_type":"4"}},{"id":2088769,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:12:47.000Z","date":"2022-07-05","kind":"gift","acquired":false,"shares":357,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":126347,"source":{"system":"sec-edgar","filing":"0001883850-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000121/edgardoc.xml","form_type":"4"}},{"id":2088768,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:12:47.000Z","date":"2022-04-06","kind":"gift","acquired":false,"shares":302,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":126704,"source":{"system":"sec-edgar","filing":"0001883850-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000121/edgardoc.xml","form_type":"4"}},{"id":2088767,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:12:47.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":57,"price":753.28,"value":42936.96,"ownership":{"direct":true},"balance_after":322432,"source":{"system":"sec-edgar","filing":"0001883850-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000121/edgardoc.xml","form_type":"4"}},{"id":2088766,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T21:12:47.000Z","date":"2022-05-24","kind":"gift","acquired":false,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":322489,"source":{"system":"sec-edgar","filing":"0001883850-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000121/edgardoc.xml","form_type":"4"}},{"id":2311963,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:08:16.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":14286,"price":700,"value":10000200.0,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price."}],"balance_after":23461,"source":{"system":"sec-edgar","filing":"0001883850-22-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000031/edgardoc.xml","form_type":"4"}},{"id":2311962,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:08:16.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":14286,"price":700.02,"value":10000485.72,"ownership":{"direct":false,"nature":"by CLAT"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price."}],"balance_after":127006,"source":{"system":"sec-edgar","filing":"0001883850-22-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000031/edgardoc.xml","form_type":"4"}},{"id":2334331,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T20:01:00.000Z","date":"2022-03-14","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001883850-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000020/edgardoc.xml","form_type":"4"}},{"id":2334330,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T20:01:00.000Z","date":"2022-01-04","kind":"gift","acquired":false,"shares":338,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":141292,"source":{"system":"sec-edgar","filing":"0001883850-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000020/edgardoc.xml","form_type":"4"}},{"id":2334329,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T20:01:00.000Z","date":"2022-03-14","kind":"tax_withholding","acquired":false,"shares":48103,"price":655.29,"value":31521414.87,"ownership":{"direct":true},"balance_after":345566,"source":{"system":"sec-edgar","filing":"0001883850-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000020/edgardoc.xml","form_type":"4"}},{"id":2334328,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T20:01:00.000Z","date":"2022-03-14","kind":"exercise","acquired":true,"shares":75000,"price":179.13,"value":13434750.0,"ownership":{"direct":true},"balance_after":393669,"source":{"system":"sec-edgar","filing":"0001883850-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000020/edgardoc.xml","form_type":"4"}},{"id":2464537,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T21:13:47.000Z","date":"2021-12-16","kind":"other","acquired":false,"shares":107,"price":635.03,"value":67948.21,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 107 shares of Company stock on December 16, 2021 at prices ranging from $635.00 to $635.06.  Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 16, 2021 at each separate price."}],"balance_after":2095,"source":{"system":"sec-edgar","filing":"0001883850-21-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000032/edgardoc.xml","form_type":"4"}},{"id":2464536,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T21:13:47.000Z","date":"2021-12-16","kind":"other","acquired":false,"shares":19,"price":634.7,"value":12059.3,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"balance_after":2202,"source":{"system":"sec-edgar","filing":"0001883850-21-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000032/edgardoc.xml","form_type":"4"}},{"id":2477921,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-10T22:35:53.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":21198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":21198,"derivative":{"exercise_price":644.54,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":21198},"source":{"system":"sec-edgar","filing":"0001708138-21-000094","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000094/edgardoc.xml","form_type":"4"}},{"id":2477920,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T22:35:53.000Z","date":"2021-10-04","kind":"gift","acquired":false,"shares":347,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":141630,"source":{"system":"sec-edgar","filing":"0001708138-21-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000094/edgardoc.xml","form_type":"4"}},{"id":2477919,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T22:35:53.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":1861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock."}],"balance_after":318669,"source":{"system":"sec-edgar","filing":"0001708138-21-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000094/edgardoc.xml","form_type":"4"}},{"id":2588886,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-27T20:01:40.000Z","date":"2021-08-25","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001708138-21-000066","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000066/edgardoc.xml","form_type":"4"}},{"id":2588885,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T20:01:40.000Z","date":"2021-08-25","kind":"tax_withholding","acquired":false,"shares":49282,"price":667.39,"value":32890313.98,"ownership":{"direct":true},"balance_after":316808,"source":{"system":"sec-edgar","filing":"0001708138-21-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000066/edgardoc.xml","form_type":"4"}},{"id":2588884,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T20:01:40.000Z","date":"2021-08-25","kind":"exercise","acquired":true,"shares":75000,"price":179.13,"value":13434750.0,"ownership":{"direct":true},"balance_after":366090,"source":{"system":"sec-edgar","filing":"0001708138-21-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000066/edgardoc.xml","form_type":"4"}},{"id":2596742,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":10039,"price":650.04,"value":6525751.56,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 10,039 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price."}],"balance_after":37747,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2596741,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-07-02","kind":"gift","acquired":false,"shares":373,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":141977,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2596740,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-04-01","kind":"gift","acquired":false,"shares":446,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":142350,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2596739,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-08-09","kind":"gift","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":291090,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2596738,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-06-14","kind":"gift","acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":308090,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2596737,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T20:05:05.000Z","date":"2021-05-27","kind":"gift","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":327090,"source":{"system":"sec-edgar","filing":"0001708138-21-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000062/edgardoc.xml","form_type":"4"}},{"id":2837149,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-02-24T21:02:02.000Z","date":"2021-02-23","kind":"exercise","acquired":false,"shares":248079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":248079},"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2837148,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-02-24T21:02:02.000Z","date":"2021-02-23","kind":"exercise","acquired":false,"shares":1921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":1921},"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2837147,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T21:02:02.000Z","date":"2021-01-19","kind":"gift","acquired":false,"shares":414,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":142796,"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2837146,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T21:02:02.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":137998,"price":458.48,"value":63269323.04,"ownership":{"direct":true},"balance_after":349090,"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2837145,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T21:02:02.000Z","date":"2021-02-23","kind":"exercise","acquired":true,"shares":248079,"price":52.03,"value":12907550.37,"ownership":{"direct":true},"balance_after":487088,"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2837144,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T21:02:02.000Z","date":"2021-02-23","kind":"exercise","acquired":true,"shares":1921,"price":52.03,"value":99949.63,"ownership":{"direct":true},"balance_after":239009,"source":{"system":"sec-edgar","filing":"0001708138-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000016/edgardoc.xml","form_type":"4"}},{"id":2949281,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-11T21:06:59.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":27680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":27680,"derivative":{"exercise_price":492,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":27680},"source":{"system":"sec-edgar","filing":"0001708138-20-000116","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000116/edgardoc.xml","form_type":"4"}},{"id":2949280,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T21:06:59.000Z","date":"2020-11-19","kind":"gift","acquired":true,"shares":2406,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by trust for grandch"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock.  The reporting person and/or the spouse of the reporting person is the trustee of each such trust."}],"balance_after":3609,"source":{"system":"sec-edgar","filing":"0001708138-20-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000116/edgardoc.xml","form_type":"4"}},{"id":2949279,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T21:06:59.000Z","date":"2020-11-19","kind":"gift","acquired":false,"shares":2406,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"balance_after":47786,"source":{"system":"sec-edgar","filing":"0001708138-20-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000116/edgardoc.xml","form_type":"4"}},{"id":2949278,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T21:06:59.000Z","date":"2020-10-06","kind":"gift","acquired":false,"shares":349,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":143210,"source":{"system":"sec-edgar","filing":"0001708138-20-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000116/edgardoc.xml","form_type":"4"}},{"id":2949277,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T21:06:59.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":2439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock."}],"balance_after":237088,"source":{"system":"sec-edgar","filing":"0001708138-20-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000116/edgardoc.xml","form_type":"4"}},{"id":3059259,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":998,"price":607.43,"value":606215.14,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 998 shares of Company stock on August 11, 2020 at prices ranging from $607.26 to $607.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":50192,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059258,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":2684,"price":606.51,"value":1627872.84,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 2,684 shares of Company stock on August 11, 2020 at prices ranging from $606.19 to $606.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":51190,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059257,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":3331,"price":605.41,"value":2016620.71,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 3,331 shares of Company stock on August 11, 2020 at prices ranging from $605.00 to $605.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":53874,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059256,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":3171,"price":604.35,"value":1916393.85,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 3,171 shares of Company stock on August 11, 2020 at prices ranging from $604.01 to $604.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":57205,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059255,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":8622,"price":603.54,"value":5203721.88,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 8,622 shares of Company stock on August 11, 2020 at prices ranging from $603.00 to $603.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":60376,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059254,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":3769,"price":602.66,"value":2271425.54,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 3,769 shares of Company stock on August 11, 2020 at prices ranging from $602.05 to $602.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":68998,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059253,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":3281,"price":601.42,"value":1973259.02,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 3,281 shares of Company stock on August 11, 2020 at prices ranging from $601.00 to $601.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":72767,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059252,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":4851,"price":600.3,"value":2912055.3,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 4,851 shares of Company stock on August 11, 2020 at prices ranging from $600.00 to $600.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":76048,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059251,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":718,"price":599.37,"value":430347.66,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 718 shares of Company stock on August 11, 2020 at prices ranging from $599.01 to $599.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":80899,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059250,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":843,"price":598.52,"value":504552.36,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 843 shares of Company stock on August 11, 2020 at prices ranging from $598.04 to $598.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":81617,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059249,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":950,"price":597.74,"value":567853.0,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 950 shares of Company stock on August 11, 2020 at prices ranging from $597.40 to $597.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":82460,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059248,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":162,"price":595.69,"value":96501.78,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 162 shares of Company stock on August 11, 2020 at prices ranging from $595.00 to $595.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 11, 2020 at each separate price."}],"balance_after":83410,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059247,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":80,"price":594.2,"value":47536.0,"ownership":{"direct":false,"nature":"by Spouse as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":83572,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059246,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-07-06","kind":"gift","acquired":false,"shares":341,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":143559,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3059245,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T20:02:40.000Z","date":"2020-05-27","kind":"gift","acquired":false,"shares":73100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":234649,"source":{"system":"sec-edgar","filing":"0001708138-20-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000094/edgardoc.xml","form_type":"4"}},{"id":3138143,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":77309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Form two of two"}],"balance_after":0,"derivative":{"exercise_price":30.63,"expiration_date":"2020-12-14","underlying":"Common Stock","underlying_shares":77309},"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138142,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":77309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":77309,"derivative":{"exercise_price":30.63,"expiration_date":"2020-12-14","underlying":"Common Stock","underlying_shares":77309},"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138141,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":77309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":154618,"derivative":{"exercise_price":30.63,"expiration_date":"2020-12-14","underlying":"Common Stock","underlying_shares":77309},"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138140,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":77309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":231927,"derivative":{"exercise_price":30.63,"expiration_date":"2020-12-14","underlying":"Common Stock","underlying_shares":77309},"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138139,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":3264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":30.63,"expiration_date":"2020-12-14","underlying":"Common Stock","underlying_shares":3264},"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138138,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:57.000Z","date":"2020-04-02","kind":"gift","acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":143900,"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138137,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:57.000Z","date":"2020-01-03","kind":"gift","acquired":false,"shares":564,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by CLAT"},"balance_after":144333,"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138136,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":100,"price":578.34,"value":57834.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":307749,"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138135,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:57.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":683,"price":577.37,"value":394343.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 683 shares of Company stock on May 21, 2020 at prices ranging from $577.08 to $577.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":307849,"source":{"system":"sec-edgar","filing":"0001708138-20-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000062/edgardoc.xml","form_type":"4"}},{"id":3138134,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":206,"price":576.47,"value":118752.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Represents volume-weighted average price of sales of 206 shares of Company stock on May 21, 2020 at prices ranging from $576.25 to $576.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F23","text":"Form one of two"}],"balance_after":308532,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138133,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2606,"price":575.34,"value":1499336.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Represents volume-weighted average price of sales of 2,606 shares of Company stock on May 21, 2020 at prices ranging from $575.00 to $575.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":308738,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138132,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2622,"price":574.69,"value":1506837.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Represents volume-weighted average price of sales of 2,622 shares of Company stock on May 21, 2020 at prices ranging from $574.13 to $574.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":311344,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138131,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2610,"price":573.55,"value":1496965.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents volume-weighted average price of sales of 2,610 shares of Company stock on May 21, 2020 at prices ranging from $573.26 to $573.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":313966,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138130,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":1356,"price":572.69,"value":776567.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents volume-weighted average price of sales of 1,356 shares of Company stock on May 21, 2020 at prices ranging from $572.20 to $572.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":316576,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138129,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2877,"price":571.32,"value":1643687.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents volume-weighted average price of sales of 2,877 shares of Company stock on May 21, 2020 at prices ranging from $571.01 to $571.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":317932,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138128,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":2049,"price":570.6,"value":1169159.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents volume-weighted average price of sales of 2,049 shares of Company stock on May 21, 2020 at prices ranging from $570.01 to $570.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":320809,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138127,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":3232,"price":569.4,"value":1840300.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents volume-weighted average price of sales of 3,232 shares of Company stock on May 21, 2020 at prices ranging from $569.00 to $569.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":322858,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138126,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":11447,"price":568.43,"value":6506818.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents volume-weighted average price of sales of 11,447 shares of Company stock on May 21, 2020 at prices ranging from $568.00 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":326090,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138125,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":9138,"price":567.51,"value":5185906.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 9,138 shares of Company stock on May 21, 2020 at prices ranging from $567.00 to $567.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":337537,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138124,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":14548,"price":566.42,"value":8240278.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 14,548 shares of Company stock on May 21, 2020 at prices ranging from $566.00 to $566.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":346675,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138123,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":12996,"price":565.47,"value":7348848.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 12,996 shares of Company stock on May 21, 2020 at prices ranging from $565.00 to $565.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":361223,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138122,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":13268,"price":564.62,"value":7491378.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 13,268 shares of Company stock on May 21, 2020 at prices ranging from $564.00 to $564.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":374219,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138121,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":11551,"price":563.53,"value":6509335.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 11,551 shares of Company stock on May 21, 2020 at prices ranging from $563.00 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":387487,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138120,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":8359,"price":562.48,"value":4701770.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 8,359 shares of Company stock on May 21, 2020 at prices ranging from $562.00 to $562.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":399038,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138119,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":10418,"price":561.4,"value":5848665.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 10,418 shares of Company stock on May 21, 2020 at prices ranging from $561.00 to $561.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":407397,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138118,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":12456,"price":560.45,"value":6980965.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 12,456 shares of Company stock on May 21, 2020 at prices ranging from $560.00 to $560.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":417815,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138117,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":8826,"price":559.51,"value":4938235.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 8,826 shares of Company stock on May 21, 2020 at prices ranging from $559.01 to $559.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":430271,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138116,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":11168,"price":558.36,"value":6235764.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 11,168 shares of Company stock on May 21, 2020 at prices ranging from $558.00 to $558.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":439097,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138115,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":5910,"price":557.51,"value":3294884.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 5,910 shares of Company stock on May 21, 2020 at prices ranging from $557.02 to $557.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":450265,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138114,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":1168,"price":556.79,"value":650330.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 1,168 shares of Company stock on May 21, 2020 at prices ranging from $556.59 to $556.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price."}],"balance_after":456175,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138113,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":39720,"price":570.97,"value":22678928.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":457343,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138112,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":77309,"price":30.63,"value":2367974.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":497063,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138111,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":39974,"price":570.97,"value":22823954.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":419754,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138110,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":77309,"price":30.63,"value":2367974.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":459728,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138109,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":39974,"price":570.97,"value":22823954.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":382419,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":77309,"price":30.63,"value":2367974.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":422393,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138107,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":39974,"price":570.97,"value":22823954.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":345084,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138106,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":77309,"price":30.63,"value":2367974.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":385058,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}},{"id":3138105,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":114674,"kind":"person","name":"VAGELOS P ROY","position":1,"cik":"0001013064","reported_name":"VAGELOS P ROY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-05-22T22:21:28.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":3264,"price":30.63,"value":99976.32,"ownership":{"direct":true},"balance_after":307749,"source":{"system":"sec-edgar","filing":"0001708138-20-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000061/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-05-22T22:21:28.000000Z,3138105"}